For a wider overview of currently available products, browse Peptides UK and Research Peptide UK
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
That contrast matters, because the most important question patients should ask is not, Will this work? The most important question is, Is this safe for me? GLOW is a three-peptide protocol built around BPC-157 , TB-500 (Thymosin Beta-4), and GHK-Cu (Copper Tripeptide-1)
After the peptide was administered, the effects in the mice were dramatic: missing fur reappeared, kidney function improved, and the treated animals were able to run twice as far as the untreated control group
Typically, you would inject sermorelin once a day at bedtime
Power outage protocol: An unopened fridge holds 2 to 8 C for about 4 hours with the door closed